1. Home
  2. STRO vs VRA Comparison

STRO vs VRA Comparison

Compare STRO & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • VRA
  • Stock Information
  • Founded
  • STRO 2003
  • VRA 1982
  • Country
  • STRO United States
  • VRA United States
  • Employees
  • STRO N/A
  • VRA N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • VRA Apparel
  • Sector
  • STRO Health Care
  • VRA Consumer Discretionary
  • Exchange
  • STRO Nasdaq
  • VRA Nasdaq
  • Market Cap
  • STRO 69.1M
  • VRA 61.7M
  • IPO Year
  • STRO 2018
  • VRA 2010
  • Fundamental
  • Price
  • STRO $0.86
  • VRA $1.98
  • Analyst Decision
  • STRO Hold
  • VRA Buy
  • Analyst Count
  • STRO 8
  • VRA 2
  • Target Price
  • STRO $3.83
  • VRA $4.00
  • AVG Volume (30 Days)
  • STRO 428.5K
  • VRA 136.5K
  • Earning Date
  • STRO 08-07-2025
  • VRA 09-10-2025
  • Dividend Yield
  • STRO N/A
  • VRA N/A
  • EPS Growth
  • STRO N/A
  • VRA N/A
  • EPS
  • STRO N/A
  • VRA N/A
  • Revenue
  • STRO $104,473,000.00
  • VRA $355,671,000.00
  • Revenue This Year
  • STRO N/A
  • VRA N/A
  • Revenue Next Year
  • STRO N/A
  • VRA $3.80
  • P/E Ratio
  • STRO N/A
  • VRA N/A
  • Revenue Growth
  • STRO N/A
  • VRA N/A
  • 52 Week Low
  • STRO $0.52
  • VRA $1.71
  • 52 Week High
  • STRO $5.17
  • VRA $6.38
  • Technical
  • Relative Strength Index (RSI)
  • STRO 55.54
  • VRA 45.82
  • Support Level
  • STRO $0.76
  • VRA $1.89
  • Resistance Level
  • STRO $0.83
  • VRA $2.07
  • Average True Range (ATR)
  • STRO 0.07
  • VRA 0.09
  • MACD
  • STRO 0.01
  • VRA 0.01
  • Stochastic Oscillator
  • STRO 52.25
  • VRA 57.69

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

Share on Social Networks: